ResApp Health is a leading digital health company developing smartphone applications for the diagnosis and management of the respiratory disease.
ResApp is also working on apps to provide clinical quality respiratory disease diagnosis and management directly to their consumers.
In December 2022, ResApp Health was acquired by Pfizer and will integrate into its newly created Pfizer Digital Health and Medicines unit.
|
RANKING: 125 Up from 129 in Public Companies - Industrial WA list | 06 Dec 2024 |
|
|
RANKING: 129 Down from 126 in Public Companies - Industrial WA list | 09 Dec 2023 |
|
NEWS: Tagged in Pfizer deal shows local potential | 15 Dec 2022 |
|
NEWS: Tagged in Healthtech banks on rising numbers | 07 Nov 2022 |
|
NEWS: Tagged in Pfizer lifts offer on ResApp deal | 03 Aug 2022 |
|
NEWS: Tagged in ResApp deal dips on test results | 21 Jun 2022 |
|
NEWS: Tagged in Pfizer tacks $80m onto ResApp offer | 14 Jun 2022 |
